Health & Biotech
‘Untap significant earnings growth’: Equity firm says EZZ Life Science stock is undervalued
Health & Biotech
The Sustainable Nutrition Group’s MD Neale Joseph eyes slice of the $10.8 billion plant-based protein market pie
Health & Biotech
Apiam makes two key acquisitions as it grows foothold in regional veterinary market
Health & Biotech
MGC Pharma set for best half-yearly results after delivering ArtemiC order in Europe
Health & Biotech
ASX Health Stocks: Biotron gets a boost with promising in vivo study for COVID-19 treatment
Health & Biotech
Check Up: Sustainable Nutrition riding high and Singular Health branches out from… health
Health & Biotech
Weed Week: Uber Eats enters Canada’s cannabis market and Montu breaks crowdfunding records
Health & Biotech
MGC Pharma US partnership validated after receiving first payment for US$24m order of CimetrA
Health & Biotech
ASX Health: 4D Medical jumps 16pc on lungs device rollout, Proteomics up 10pc on UK deal
Health & Biotech
Paul Hopper on whether his new venture Radiopharm Theranostics will be a takeover target, and the keys to biotech success
Health & Biotech
ASX Health: Twiggy Forrest’s investment fund takes a stake in this ASX cannabis stock
Health & Biotech
Prescient bolsters board with experienced and leading figures in CAR-T therapy
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.